SCHEMBL8993497

SCHEMBL8993497

NS(=O)(=O)c1ncc(CO)c(C2=CCCC2)c1CO

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 1/20 0.31
GRM2 Q14416 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8993563 0.87 PTGS2 (0.35)
SCHEMBL8993537 0.82
SCHEMBL8993451 0.62 PTGS2 (0.39)
SCHEMBL8993449 0.60 PTGS2 (0.45) CSF1RGRM2
SCHEMBL8993654 0.59 F2RL1 (0.36) GRM2
SCHEMBL8993514 0.59 PTGS2 (0.52) GRM2
SCHEMBL8993495 0.57 PIM1 (0.37) GRM2
SCHEMBL8993549 0.57 PTGES2 (0.36) GRM2
SCHEMBL6733073 0.56 PTGES2 (0.49) GRM2
SCHEMBL20401017 0.56 ACMSD (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0724566-A1 1,2-DIARYLCYCLOPENTENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-07 EP disclosed
WO-1995011883-A1 1,2-DIARYLCYCLOPENTENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-05-04 WO disclosed